Publications by authors named "Peter Durrer"

Claim this Profile
P
Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers.
Hedvika Lazar, Michael P Horn, Adrian W Zuercher, Martin A Imboden, Peter Durrer

Antimicrob Agents Chemother· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.
Cornelia Feiterna-Sperling, Rainer Brönnimann, Annedore Tischer, Peter Stettler, Peter Durrer

Pediatr Infect Dis J· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial.
Markus Pfister, Oliver Kürsteiner, Helene Hilfiker, Didier Favre, Peter Durrer

Am J Trop Med Hyg· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children.
Güler Kanra, Paola Marchisio, Cornelia Feiterna-Sperling, Gerhard Gaedicke, Hedvika Lazar, Peter Durrer

Pediatr Infect Dis J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis